Dyadic International Inc., DE
NASDAQ:DYAI 4:00:00 PM EDT
| Market Cap (Intraday) | 46.07M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.70 |
| 50-Day MA | $1.55 |
| 200-Day MA | $1.69 |
Dyadic International Inc., DE Stock, NASDAQ:DYAI
1044 North US Highway One, Suite 201, Jupiter, Florida 33477-5094
United States of America
Phone: +1.561.743.8333
Number of Employees:
Description
Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.